Abstract:In this paper, QSPR models were developed for in vivo blood-brain partitioning data (logBB) of a large data set consisting of 115 diverse organic compounds. The best model is based on three descriptors: n-octanol/water partition coefficient calculated using the SLOGP approach, logP; high-charged polar surface areas based on the Gasteiger partial charges, HCPSA, and the excessive molecular weight larger than 360, MW(360). The model bears good statistical significance, n = 78, r = 0.88, q = 0.86, s = 0.36, F = 81.5. The actual prediction potential of the model was validated through two external validation sets of 37 diverse compounds. The predicted results demonstrate that the model bears better prediction potential than many other models and can be used for logBB estimations for drug and drug-like molecules. Comparison of several logP calculation approaches suggests that logP calculated by SLOGP can be used as a significant descriptor for the prediction of molecular transport properties because SLOGP gives the most similar results with CLOGP. The QSPR model indicates that larger polar surface areas have a more negative contribution to logBB, but the absolute partial charges on the atoms surrounded by the polar surfaces should be larger than 0.10|e|. Meanwhile, tight junction membranes limit the size of hydrophilic molecules that can cross the membrane with a molecular weight of approximately 360, because when a molecule's weight is larger than 360 it shows a negative contribution to logBB. The computations of molecular surface, partial charges, logP, and logBB have been accomplished using a program called Drug-BB. Moreover, to improve the efficiency of the computations of logP, we made an extensive reparametrization of SLOGP, and the newly developed SLOGP model is only based on simple atomic addition. Further, we developed a set of parameters to calculate the topological polar surface area (TPSA), thus the high-charged topological polar surface area (HCTPSA) could be estimated from the 2D connection information of a molecule. Adopting the new strategies, the estimations of logP, HCTPSA, and logBB are only based on the topological structure of a molecule and therefore, can be used for fast screening of virtual libraries having millions of molecules.

A prediction model for blood–brain barrier permeation and analysis on its parameter biologically

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

Predicting Blood-Brain Barrier Penetration of Drugs Using an Artificial Neural Network

Prediction of blood‐brain barrier permeability using machine learning approaches based on various molecular representation

Predicting blood-brain barrier penetration from molecular weight and number of polar atoms.

In Silico Prediction of Blood-Brain Barrier Permeability of Chemical Compounds through Molecular Feature Modeling

Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.

Natural‐Language Processing (NLP) based feature extraction technique in Deep‐Learning model to predict the Blood‐Brain‐Barrier permeability of molecules

Application of artificial neural network to predict benzo[a]pyrene based on multiple quality of smoked sausage

Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds

Attentive graph neural network models for the prediction of blood-brain barrier permeability

Development of QSAR models to predict blood-brain barrier permeability

DeePred-BBB: A Blood Brain Barrier Permeability Prediction Model With Improved Accuracy

Predicting blood–brain barrier permeability of molecules with a large language model and machine learning

A merged molecular representation deep learning method for blood-brain barrier permeability prediction

Exploring blood–brain barrier passage using atomic weighted vector and machine learning

Modeling the Blood-Brain Barrier Permeability of Potential Heterocyclic Drugs via Biomimetic IAM Chromatography Technique Combined with QSAR Methodology

Application of parallel artificial membrane permeability assay technique and chemometric modeling for blood–brain barrier permeability prediction of protein kinase inhibitors

Adme Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors

Functional Blood-Brain Barrier Model with Tight Connected Minitissue by Liquid Substrates Culture.

A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors